
    
      Through the collection of outcome data, Lung Institute aims to explore and describe the
      safety and efficacy of autologous cellular therapy for chronic lung disease with
      dissemination to the public and to the medical community for the advancement of regenerative
      medicine. The study aims to confirm the safety of autologous cell therapy, explore the effect
      of autologous cell therapy treatment on pulmonary function, and to describe the anecdotal
      quality of life changes of patients following treatment using both quantitative and
      qualitative measures.
    
  